Monoamine oxidase inhibitor and Parkinson's disease

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Monoamine oxidase inhibitor and Parkinson's disease

Monoamine oxidase inhibitor vs. Parkinson's disease

Monoamine oxidase inhibitors (MAOIs) are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.

Anxiety

Anxiety is an emotion characterized by an unpleasant state of inner turmoil, often accompanied by nervous behaviour such as pacing back and forth, somatic complaints, and rumination.

Anxiety and Monoamine oxidase inhibitor · Anxiety and Parkinson's disease · See more »

Dopamine

Dopamine (DA, a contraction of 3,4-dihydroxyphenethylamine) is an organic chemical of the catecholamine and phenethylamine families that plays several important roles in the brain and body.

Dopamine and Monoamine oxidase inhibitor · Dopamine and Parkinson's disease · See more »

Enzyme

Enzymes are macromolecular biological catalysts.

Enzyme and Monoamine oxidase inhibitor · Enzyme and Parkinson's disease · See more »

Major depressive disorder

Major depressive disorder (MDD), also known simply as depression, is a mental disorder characterized by at least two weeks of low mood that is present across most situations.

Major depressive disorder and Monoamine oxidase inhibitor · Major depressive disorder and Parkinson's disease · See more »

Monoamine oxidase

L-Monoamine oxidases (MAO) are a family of enzymes that catalyze the oxidation of monoamines.

Monoamine oxidase and Monoamine oxidase inhibitor · Monoamine oxidase and Parkinson's disease · See more »

Monoamine oxidase B

Monoamine oxidase B, also known as MAOB, is an enzyme that in humans is encoded by the MAOB gene.

Monoamine oxidase B and Monoamine oxidase inhibitor · Monoamine oxidase B and Parkinson's disease · See more »

Obsessive–compulsive disorder

Obsessive–compulsive disorder (OCD) is a mental disorder where people feel the need to check things repeatedly, perform certain routines repeatedly (called "rituals"), or have certain thoughts repeatedly (called "obsessions").

Monoamine oxidase inhibitor and Obsessive–compulsive disorder · Obsessive–compulsive disorder and Parkinson's disease · See more »

Panic disorder

Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks.

Monoamine oxidase inhibitor and Panic disorder · Panic disorder and Parkinson's disease · See more »

Rasagiline

Rasagiline (Azilect, TVP-1012, N-propargyl-1(R)-aminoindan) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.

Monoamine oxidase inhibitor and Rasagiline · Parkinson's disease and Rasagiline · See more »

Safinamide

Safinamide (INN; brand name Xadago) is a drug used as an add-on treatment for Parkinson's disease during "off" episodes; it has multiple modes of action, including the inhibition of monoamine oxidase B. See for updates.

Monoamine oxidase inhibitor and Safinamide · Parkinson's disease and Safinamide · See more »

Selegiline

Selegiline, also known as L-deprenyl, is a substituted phenethylamine.

Monoamine oxidase inhibitor and Selegiline · Parkinson's disease and Selegiline · See more »

Social anxiety disorder

Social anxiety disorder (SAD), also known as social phobia, is an anxiety disorder characterized by a significant amount of fear in one or more social situations, causing considerable distress and impaired ability to function in at least some parts of daily life.

Monoamine oxidase inhibitor and Social anxiety disorder · Parkinson's disease and Social anxiety disorder · See more »